This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Belmarra Nutritionals
Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows the tie between consumption of caffeine and Alzheimer’s disease.
Toronto, ON (PRWEB) June 30, 2012
Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that shows the tie between consumption of caffeine and Alzheimer’s disease.
A new study published in the Journal of Alzheimer’s disease (June 5th, 2012), has discovered that a high daily intake of caffeine could lead to some promising results.
New diagnostic guidelines allow doctors to identify Alzheimer’s disease in its earlier stages before it completely develops. It is estimated that 10 million Americans fall into one of the three pre- Alzheimer’s stages and this number is on the rise. Mild cognitive impairment, or MCI, is one of the pre- Alzheimer’s stages and it is used to describe patients who have some Alzheimer’s pathology in their brains, who experience a degree of short-term memory loss and who are likely to develop dementia within three years. The study was conducted by researchers from the University of Miami and the University of South Florida and it included 124 MCI participants over the age of 65, from Tampa and Miami.
The researchers measured blood caffeine levels of the participants at the onset of the study, and then measured them again at a two-to-four year follow up session. The researchers found that the participants with mild cognitive impairment who progressed to dementia by the time of the follow-up had significantly lower (51 percent less) blood caffeine levels than those participants whose MCI remained stable. In fact, not one of the MCI participants who developed Alzheimer’s had caffeine levels above the critical level of 1200 ng/ml. In contrast, “We found that 100 percent of the MCI patients with plasma caffeine levels above the critical level (indicative of the consumption of several cups of coffee prior to the blood test) experienced no conversion to Alzheimer’s disease during the two-to-four year follow-up period,” said study co-author Dr. Gary Arendash.
CEO of Bel Marra Health Jim Chiang mentioned that, “It should be noted that coffee appeared to be the primary if not only source of caffeine for the study participants, and other caffeinated beverages may not produce the same dementia preventing effects.”
According to USF’s study authors Dr. Cao and Dr. Arendash, caffeine appears to act synergistically with a certain component of coffee, and when consumed together, they increase blood levels of a growth factor that is suspected to halt the dementia process. In addition, previous studies done on mice found that caffeine alone did not produce the same dementia reducing effects as caffeinated coffee did.
(SOURCE: “The Cleveland Clinic,” Types of Dementia, June 2012)
Bel Marra Health, as the distributor of Smart Pill, offers high-quality vitamins and nutritional supplements in formulations designed to address specific health concerns. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going that extra mile to ensure our health conscious customers are getting top quality products. For more information on Bel Marra Nutritionals visit http://www.belmarrahealth.com or call 1-866-531-0466.
Bel Marra Nutritionals, Inc.
100-7000 Pine Valley
Woodbridge, ON L4L 4Y8
pr(at)belmarrahealth(dot)com
866-531-0466
http://www.belmarrahealth.com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/6/prweb9651439.htm
